Kinesio Tape for dogs?

You betcha! Albuquerque, New Mexico, USA, Sept. 24, 2020 (GLOBE NEWSWIRE) — You may have heard about Kinesio Taping on people, from elite athletes to medical patients. Maybe you know about someone who uses Kinesio Equine Taping on a horse. Now there is a Kinesio Tape specially designed and formulated for your furry friend. Kinesio

Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom

Clinical trial to enroll up to 10,000 volunteers across the UK to assess whether NVX-CoV2373 is effective in the prevention of COVID-19 GAITHERSBURG, Md., Sept. 24, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has initiated its first Phase

Rhizen Pharmaceuticals S.A. Announces Publication of Clinical Data from the Phase I/Ib study of Tenalisib (RP6530) in Patients with Relapsed/Refractory T-Cell Lymphoma (TCL)

La Chaux-de-Fonds, Switzerland, Sept. 24, 2020 (GLOBE NEWSWIRE) — Rhizen Pharmaceuticals S.A. today announced the publication of the results from the Phase I/Ib study of Tenalisib (RP6530), the company’s novel next generation dual PI3K δ/γ inhibitor, in the journal Cancers. — Single-agent Tenalisib was well tolerated with a good overall response rate (ORR) in both peripheral and cutaneous

Phoenix Software International Delivers Optional Software Development Kit for its Data Entry Software Suite

EL SEGUNDO, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — Tomorrow, Friday, September 25, 2020, Phoenix Software International, Inc., will release an update to its web- and desktop-based data entry software suite, Entrypoint. The new release, Entrypoint 16.1, includes an optional software development kit (SDK), which allows developers to extend the core functionality of Entrypoint using

Philips expands peripheral vascular disease portfolio with the QuickClear mechanical thrombectomy system for blood clot removal

September 24, 2020 Powerfully simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system Intuitive design eliminates the need for capital equipment, with easy setup supporting faster procedures times Significantly smaller footprint provides the same or greater aspiration power as currently-available thrombectomy devices [1]       Amsterdam, the Netherlands – Royal Philips (NYSE: